Altan Lale, Bingöl Umit, Aykaç Mehtap, Yurtkuran Merih
Rheumatic Disease and Hydrotherapy section, Atatürk Rehabilitation Center, Uludağ University Medical Faculty, Bursa, Turkey.
Rheumatol Int. 2005 Jan;25(1):23-7. doi: 10.1007/s00296-003-0396-y. Epub 2003 Dec 12.
Low-energy laser therapy has been applied in several rheumatoid and soft tissue disorders with varying rates of success. The objective of our study was to investigate the effect of laser therapy on cervical myofascial pain syndrome with a placebo-controlled double-blind prospective study model. It was performed with a total of 53 patients (35 females and 18 males) with cervical myofascial pain syndrome. In group 1 (n = 23), GaAs laser treatment was applied over three trigger points bilaterally and also one point in the taut bands in trapezius muscle bilaterally with a frequency of 1000 Hz for 2 min over each point once a day for 10 days during a period of 2 weeks. In group 2 (n = 25), the same treatment protocol was given, but the laser instrument was switched off during applications. All patients in both groups were instructed to perform daily isometric exercises and stretching just short of pain for 2 weeks at home. Evaluations were performed just before treatment (week 0), immediately after (week 2), and 12 weeks later (week 14). Evaluation parameters included pain, algometric measurements, and cervical lateral flexion. Statistical analysis was done on data collected from three evaluation stages. The results were evaluated in 48 patients (32 females, 16 males). Week 2 and week 14 results showed significant improvement in all parameters for both groups. However, comparison of the percentage changes both immediately and 12 weeks after treatment did not show a significant difference relative to pretreatment values. In conclusion, the results of our study have not shown the superiority of GaAs laser therapy over placebo in the treatment of cervical myofascial pain syndrome, but we suggest that further studies on this topic be done using different laser types and dosages in larger patient populations.
低能量激光疗法已应用于多种类风湿性疾病和软组织疾病,成功率各不相同。我们研究的目的是采用安慰剂对照双盲前瞻性研究模型,调查激光疗法对颈部肌筋膜疼痛综合征的影响。该研究共纳入了53例颈部肌筋膜疼痛综合征患者(35例女性,18例男性)。第1组(n = 23),采用砷化镓激光双侧照射三个触发点,同时双侧斜方肌紧张带各照射一点,频率为1000 Hz,每个点照射2分钟,每天一次,共10天,为期2周。第2组(n = 25),给予相同的治疗方案,但在照射时关闭激光仪器。两组所有患者均被要求在家中进行为期2周的每日等长运动和接近疼痛阈值的拉伸运动。在治疗前(第0周)、治疗后立即(第2周)和12周后(第14周)进行评估。评估参数包括疼痛、痛觉测量和颈部侧屈。对从三个评估阶段收集的数据进行统计分析。结果在48例患者(32例女性,16例男性)中进行评估。第2周和第14周的结果显示两组所有参数均有显著改善。然而,治疗后立即和12周后的百分比变化与治疗前值相比没有显著差异。总之,我们的研究结果并未显示砷化镓激光疗法在治疗颈部肌筋膜疼痛综合征方面优于安慰剂,但我们建议在更大的患者群体中使用不同类型和剂量的激光对该主题进行进一步研究。